above, you agree to the terms of use & privacy policy bull or bear, seeking alpha is there markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. create free account pfe pfizer inc. stock price & overview analyze with ai follow $ ...
MarketsTrump Looms Large Over Stock Markets. Why Chips, Fed Are Just the Beginning and 5 Other Things to Know Today. Jan. 14, 2025 at 7:11 a.m. ET Biotech and PharmaPfizer CEO Is Optimistic Ahead of the Trump Administration. ‘The Opportunities Outweigh the Risks.’ ...
Estimates for Novartis’ 2024 earnings have risen from $7.53 to $7.65 per share over the past 60 days. For 2025, earnings estimates have risen from $8.29 to $8.43 per share over the same timeframe. Year to date, Novartis’ stock has declined 1.8%. Novartis beat estimates in three of th...
Nintendo Switch 2 Price and Release Window Leak 37m ago NTDOY VZ Earnings: Verizon Beats Estimates in Q4, Subscribers Hit Five-Year High 39m ago T VZ Electronic Arts Stock Faces Analyst Downgrades & Price Target Cuts 1h ago EA Trump Demands Interest Rate Cuts Despite Fed Resistance 2h ago ...
So, is Pfizer stock a buy or a sell today? Pfizer Stock Fundamentals In the September quarter, Pfizer earned an adjusted $1.06 per share on $17.7 billion in sales. Both beat the Street's forecast. Earnings reversed from a year-earlier loss, while sales climbed 31%. In addition to the ...
And how are we balancing the need to kind of take stock and cut while ensuring that high potential opportunities are getting appropriately accelerated through the pipeline? Albert Bourla--Chairman and Chief Executive Officer Then maybe I will ask the two R&D heads to comment on that. Please, le...
of Pfizer Inc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Pfizer match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise inPfizer's stock price....
This new authorization represented approximately 10.1% of shares outstanding at the stock price at the time of the announcement.Sale of select assets of BioReference Health expected to close toward the end of the third quarter. OPKO entered into an agreement in March 2024 to sell BioReference ...
The Listing Committee of the Stock Exchange of Hong Kong approved the listing of 115,928,803 additional shares subscribed by Pfizer at a price of approximately HK$13.37 per share. The shares represent approximately 9.90 percent of the issued share capital of CStone as enlarged by the a...
As you know, we missed our initial internal projections and Street expectations predominantly related to our COVID products, which affected our stock price performance. Despite however this challenging year, there were a few great things that happened in 2023 that may have gotten lost amid the mix...